| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immune Therapeutics, Inc. | Chief Financial Officer | Common Stock | 409,000 | 10 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000149315223005800-farmer-glen-a-2023-02-10 | Immune Therapeutics, Inc. | 10 Feb 2023 | 1 | +$18,405 | 4 | Chief Financial Officer | 22 Feb 2023, 18:00 |
| /report/000121390022080141-farmer-glen-a-2022-08-02 | Immune Therapeutics, Inc. | 02 Aug 2022 | 0 | $0 | 3 | Chief Financial Officer | 15 Dec 2022, 15:45 |